EL Pritchett, EA McCarthy, WE Wilkinson - Annals of internal medicine, 1991 - ncbi.nlm.nih.gov OBJECTIVE: To test the hypothesis that propafenone, administered orally,
prevents symptomatic paroxysmal supraventricular arrhythmias. DESIGN: a 6-month,
open-label, dose-finding phase followed by a randomized, double-blind, ... Cited by 109 - Related articles - All 3 versions
- ►ahajournals.org [PDF] JL Anderson, EM Gilbert, BL Alpert, RW … - Circulation, 1989 - Am Heart Assoc Paroxysmal atrial fibrillation (PAF) is a problematic clinical arrhythmia that
is usually symptomatic. Unfortunately, few adequate trials and trial methods are
available for assessment of the value of therapy, and traditional treatment ... Cited by 162 - Related articles - All 3 versions
SJ Connolly, DL Hoffert - The American journal of cardiology, 1989 - Elsevier To evaluate the efficacy of propafenone for suppression of recurrent paroxysmal
symptomatic atrial fibrillation (AF), patients with frequent episodes of AF
entered an open-label, dose-ranging study to determine the maximal ... Cited by 63 - Related articles - All 3 versions
BW Karlson, I Torstensson, C Abjorn, SO … - European Heart Journal, 1988 - Eur Soc Cardiology KEY WORDS: Atrial fibrillation, disopyramide, cardioversion. In this multicentre
study, 90 patients who left hospital in sinus rhythm after electroconversion of
atrial fibrillation were randomized to double-blind treatment with either ... Cited by 72 - Related articles - All 2 versions
SC Reimold, CO Cantillon, PL Friedman, EM … - The American journal of cardiology, 1993 - ncbi.nlm.nih.gov 1: Am J Cardiol. 1993 Mar 1;71(7):558-63. Propafenone versus sotalol for
suppression of recurrent symptomatic atrial fibrillation. ... Cited by 199 - Related articles - BL Direct - All 2 versions
MD Winniford, KL Fulton, LD Hillis - The American journal of cardiology, 1984 - cat.inist.fr Long-term therapy of paroxysmal supraventricular tachycardia: a randomized,
double-blind comparison of digoxin, propranolol and verapamil. ... Cited by 39 - Related articles - All 2 versions
JL Anderson, ML Platt, T Guarnieri, TL Fox, MJ … - The American journal of cardiology, 1994 - ncbi.nlm.nih.gov 1: Am J Cardiol. 1994 Sep 15;74(6):578-84. Flecainide acetate for paroxysmal
supraventricular tachyarrhythmias. The Flecainide Supraventricular ... Cited by 31 - Related articles - BL Direct - All 2 versions
… , MD WINNIFORD, WS WALKER, RE RUDE, … - Annals of Internal Medicine, 1982 - Am Coll Physicians The effectiveness and safety of orally administered verapamil was tested in 11
patients with frequent paroxysmal supraventricular tachycardia. In a 4-month
randomized, double-blind, placebo-controlled trial, the frequency of ... Cited by 44 - Related articles - All 2 versions
EL Pritchett, WE Wilkinson - The American journal of cardiology, 1991 - ncbi.nlm.nih.gov In a recent clinical trial, the class Ic antiarrhythmic drugs encainide and
flecainide were found to be associated with an increased mortality risk in
patients with new myocardial infarction and ventricular arrhythmias. The ... Cited by 57 - Related articles - All 2 versions
- ►ahajournals.org [PDF] RW Henthorn, AL Waldo, JL Anderson, EM … - Circulation, 1991 - Am Heart Assoc Oral flecainide acetate was administered to 34 patients with documented
symptomatic paroxysmal supraventricular tachycardia (PSVT) with a double-blind,
placebo-controlled, 8-week crossover trial design. PSVT was defined as a ... Cited by 30 - Related articles - All 5 versions
